We first assessed the efficacy of Eritoran treatment of a low-dose viral infection prior to exposure to Sp3. Our findings indicate that even a sublethal exposure to influenza virus greatly enhances susceptibility to bacterial pneumonia, consistent with the findings of other studies. This evidence concerns the gene SP3 and bacterial pneumonia.